Format

Send to

Choose Destination
See comment in PubMed Commons below
BMJ Open. 2017 Jun 30;7(6):e016701. doi: 10.1136/bmjopen-2017-016701.

A cross-sectional analysis of pharmaceutical industry-funded events for health professionals in Australia.

Author information

1
Center of Research in Medical Pharmacology, The University of Insubria, Varese, Italy.
2
Charles Perkins Centre and Faculty of Pharmacy, The University of Sydney, Camperdown, Australia.
3
Faculty of Health Sciences and Medicine, Bond University, Robina, Australia.
4
Sydney Medical School - Public Health, The University of Sydney, Camperdown, Australia.
5
School of Medicine and Public Health, University of Newcastle, Newcastle, Australia.

Abstract

OBJECTIVES:

To analyse patterns and characteristics of pharmaceutical industry sponsorship of events for Australian health professionals and to understand the implications of recent changes in transparency provisions that no longer require reporting of payments for food and beverages.

DESIGN:

Cross-sectional analysis.

PARTICIPANTS AND SETTING:

301 publicly available company transparency reports downloaded from the website of Medicines Australia, the pharmaceutical industry trade association, covering the period from October 2011 to September 2015.

RESULTS:

Forty-two companies sponsored 116 845 events for health professionals, on average 608 per week with 30 attendees per event. Events typically included a broad range of health professionals: 82.0% included medical doctors, including specialists and primary care doctors, and 38.3% trainees. Oncology, surgery and endocrinology were the most frequent clinical areas of focus. Most events (64.2%) were held in a clinical setting. The median cost per event was $A263 (IQR $A153-1195) and over 90% included food and beverages.

CONCLUSIONS:

Over this 4-year period, industry-sponsored events were widespread and pharmaceutical companies maintained a high frequency of contact with health professionals. Most events were held in clinical settings, suggesting a pervasive commercial presence in everyday clinical practice. Food and beverages, known to be associated with changes to prescribing practice, were almost always provided. New Australian transparency provisions explicitly exclude meals from the reporting requirements; thus, a large proportion of potentially influential payments from pharmaceutical companies to health professionals will disappear from public view.

KEYWORDS:

education & training (see medical education &training); health policy; public health

PMID:
28667226
DOI:
10.1136/bmjopen-2017-016701
Free full text

Conflict of interest statement

Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author). BM reports that she was an expert witness on behalf of plaintiffs in a Canadian class action suit concerning cardiovascular risks of a testosterone gel. None of the authors received any payments, funding or other financial support from pharmaceutical manufacturers. The authors declare no other relationships or activities that could appear to have influenced the submitted work

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Support Center